These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 18814888

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis.
    Jadasz JJ, Aigner L, Rivera FJ, Küry P.
    Cell Tissue Res; 2012 Jul; 349(1):331-47. PubMed ID: 22322424
    [Abstract] [Full Text] [Related]

  • 8. Regeneration and repair in multiple sclerosis: the view of experimental pathology.
    Blakemore WF.
    J Neurol Sci; 2008 Feb 15; 265(1-2):1-4. PubMed ID: 17459413
    [Abstract] [Full Text] [Related]

  • 9. The pathogenesis and basis for treatment in multiple sclerosis.
    Compston A.
    Clin Neurol Neurosurg; 2004 Jun 15; 106(3):246-8. PubMed ID: 15177777
    [Abstract] [Full Text] [Related]

  • 10. Enhancing central nervous system remyelination in multiple sclerosis.
    Dubois-Dalcq M, Ffrench-Constant C, Franklin RJ.
    Neuron; 2005 Oct 06; 48(1):9-12. PubMed ID: 16202704
    [Abstract] [Full Text] [Related]

  • 11. Growth factors and remyelination in the CNS.
    Woodruff RH, Franklin RJ.
    Histol Histopathol; 1997 Apr 06; 12(2):459-66. PubMed ID: 9151135
    [Abstract] [Full Text] [Related]

  • 12. [Transplantation of myelinating cells as regenerative therapy for multiple sclerosis - experimental basis and present state of clinical studies].
    Stangel M.
    Nervenarzt; 2002 Oct 06; 73(10):937-45. PubMed ID: 12376881
    [Abstract] [Full Text] [Related]

  • 13. Prospects of cell therapy for disorders of myelin.
    Ben-Hur T, Goldman SA.
    Ann N Y Acad Sci; 2008 Oct 06; 1142():218-49. PubMed ID: 18990129
    [Abstract] [Full Text] [Related]

  • 14. Using stem cells in multiple sclerosis therapies.
    Muraro PA, Cassiani-Ingoni R, Martin R.
    Cytotherapy; 2004 Oct 06; 6(6):615-20. PubMed ID: 15764028
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic strategies in multiple sclerosis. II. Long-term repair.
    Scolding N.
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct 29; 354(1390):1711-20. PubMed ID: 10603622
    [Abstract] [Full Text] [Related]

  • 16. The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes.
    Blakemore WF.
    Neuropathol Appl Neurobiol; 2005 Feb 29; 31(1):1-10. PubMed ID: 15634226
    [Abstract] [Full Text] [Related]

  • 17. Use of stem cells for the treatment of multiple sclerosis.
    Karussis D, Kassis I.
    Expert Rev Neurother; 2007 Sep 29; 7(9):1189-201. PubMed ID: 17868017
    [Abstract] [Full Text] [Related]

  • 18. Stem cell transplantation in multiple sclerosis.
    Uccelli A, Mancardi G.
    Curr Opin Neurol; 2010 Jun 29; 23(3):218-25. PubMed ID: 20375893
    [Abstract] [Full Text] [Related]

  • 19. [Candidate cells for remyelinating of the central nervous system].
    Nait Oumesmar B, Lachapelle F, Decker L, Avellana-Adalid V, Vitry S, Baron-Van Evercooren A.
    Rev Neurol (Paris); 1998 Sep 29; 154(8-9):592-9. PubMed ID: 9809374
    [No Abstract] [Full Text] [Related]

  • 20. Stem cell therapy for demyelinating disorders.
    Pazour J, Mokrý J.
    Acta Medica (Hradec Kralove); 2006 Sep 29; 49(2):79-85. PubMed ID: 16956113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.